The COINCIDE Trial

The COINCIDE trial aims to evaluate the effectiveness and cost-effectiveness of collaborative care in treating symptoms of depression in patients that have coronary heart disease (CHD) and/or diabetes. Collaborative care is a method of care management in which the patient, medical doctors and other specialists collaborate to design and deliver a structured care programme for the patient. In the USA there is growing evidence suggesting that collaborative care may be beneficial to patients with depression as well as CHD and/or diabetes.

The trial is open to patients in North West England that have a diagnosis of CHD and/or diabetes as well as depressive symptoms. General practice surgeries that enter the study will be randomly allocated to provide collaborative care or usual care for patients that participate in the trial. Patients that register for the trial will receive either their usual care or collaborative care.

Trial participants will have the chance to receive collaborative care, which has been shown to reduce symptoms of depression for CHD and/or diabetes patients in the USA. We do not anticipate any side effects, risks or disadvantages for people who participate in this research.

The study is being run by the Collaboration for Leadership in Applied Health Research and Care (CLAHRC) at the University of Manchester (GM CLAHRC). Recruitment will begin in March 2012 and will continue for six months.  The study is funded by the National Institute for Health Research (NIHR).

For information about the study please contact Andrea Cherrington on 0161 275 7616.